Vlado Perkovic's Publications

Hemodynamic effects of the dipeptidyl peptidase-4 inhibitor linagliptinwith renin-angiotensin system inhibitors in type 2 diabetic patientswith albuminuria
Journal articles
2019
Journal of Hypertension
Effects of canagliflozin on amputation risk in type 2 diabetes: The CANVAS Program
Journal articles
2019
Diabetologia
Effects of Canagliflozin on Heart Failure Outcomes Associated With Preserved and Reduced Ejection Fraction in Type 2 Diabetes Mellitus: Results From the CANVAS Program
Journal articles
2019
Circulation
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
Journal articles
2019
The Lancet
Investigating the stratified efficacy and safety of pharmacological blood pressure-lowering: An overall protocol for individual patient-level data meta-analyses of over 300 000 randomised participants in the new phase of the Blood Pressure Lowering Treatment Trialists Collaboration (BPLTTC)
Journal articles
2019
BMJ Open
Blood pressure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Journal articles
2019
Kidney International
Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: A systematic review and meta-analysis
Journal articles
2019
Diabetes, Obesity and Metabolism
SUN-LB015 Baseline Characteristics and Effects on CV and Kidney Outcomes with Linagliptin Versus Placebo, Across GFR Categories in CARMELINA
Journal articles
2019
Journal of the Endocrine Society
Effect of extended hours dialysis on sleep quality in a randomized trial
Journal articles
2019
Nephrology
Proteinuria reduction as a surrogate end point in trials of IgA nephropathy
Journal articles
2019
Clinical Journal of the American Society of Nephrology
Effect of methylprednisolone on acute kidney injury in patients undergoing cardiac surgery with a cardiopulmonary bypass pump: A randomized controlled trial
Journal articles
2019
CMAJ
Hyperkalemia and renin-angiotensin aldosterone system inhibitor therapy in chronic kidney disease: A general practice-based, observational study
Journal articles
2019
PLoS ONE
Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials
Journal articles
2019
The Lancet Diabetes and Endocrinology
Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies
Journal articles
2019
The Lancet Diabetes and Endocrinology
Relationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global Consortium
Journal articles
2019
American Journal of Kidney Diseases
Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA
Journal articles
2019
Circulation
Status of care for end stage kidney disease in countries and regions worldwide: International cross sectional survey
Journal articles
2019
The BMJ
Effect of canagliflozin on renal and cardiovascular outcomes across different levels of albuminuria: Data from the CANVAS program
Journal articles
2019
Journal of the American Society of Nephrology
Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction on Vascular End-points in Chronic Kidney Disease (IMPROVE-CKD) study
Journal articles
2019
BMJ Open
Canagliflozin and Stroke in Type 2 Diabetes Mellitus: Results from the Randomized CANVAS Program Trials
Journal articles
2019
Stroke
Randomised controlled trial of the impact of haemodiafiltration on uraemic neuropathy: FINESSE study protocol
Journal articles
2019
BMJ Open
Adiposity and risk of decline in glomerular filtration rate: Meta-analysis of individual participant data in a global consortium
Journal articles
2019
BMJ (Online)
Acute Increases in Serum Creatinine after Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes Mellitus: The ADVANCE Trial
Journal articles
2019
Hypertension
Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults with Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial
Journal articles
2019
JAMA - Journal of the American Medical Association
China Kidney Disease Network (CK-NET) 2015 Annual Data Report
Journal articles
2019
KIDNEY INTERNATIONAL SUPPLEMENTS
Blood pressure: at what level is treatment worthwhile? (vol 42, pg 127, 2019)
Journal articles
2019
AUSTRALIAN PRESCRIBER

Previous Next

Vlado Perkovic's Publications

Hemodynamic effects of the dipeptidyl peptidase-4 inhibitor linagliptinwith renin-angiotensin system inhibitors in type 2 diabetic patientswith albuminuria

Effects of canagliflozin on amputation risk in type 2 diabetes: The CANVAS Program

Effects of Canagliflozin on Heart Failure Outcomes Associated With Preserved and Reduced Ejection Fraction in Type 2 Diabetes Mellitus: Results From the CANVAS Program

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Investigating the stratified efficacy and safety of pharmacological blood pressure-lowering: An overall protocol for individual patient-level data meta-analyses of over 300 000 randomised participants in the new phase of the Blood Pressure Lowering Treatment Trialists Collaboration (BPLTTC)

Blood pressure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: A systematic review and meta-analysis

SUN-LB015 Baseline Characteristics and Effects on CV and Kidney Outcomes with Linagliptin Versus Placebo, Across GFR Categories in CARMELINA

Effect of extended hours dialysis on sleep quality in a randomized trial

Proteinuria reduction as a surrogate end point in trials of IgA nephropathy

Effect of methylprednisolone on acute kidney injury in patients undergoing cardiac surgery with a cardiopulmonary bypass pump: A randomized controlled trial

Hyperkalemia and renin-angiotensin aldosterone system inhibitor therapy in chronic kidney disease: A general practice-based, observational study

Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials

Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies

Relationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global Consortium

Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA

Status of care for end stage kidney disease in countries and regions worldwide: International cross sectional survey

Effect of canagliflozin on renal and cardiovascular outcomes across different levels of albuminuria: Data from the CANVAS program

Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction on Vascular End-points in Chronic Kidney Disease (IMPROVE-CKD) study

Canagliflozin and Stroke in Type 2 Diabetes Mellitus: Results from the Randomized CANVAS Program Trials

Randomised controlled trial of the impact of haemodiafiltration on uraemic neuropathy: FINESSE study protocol

Adiposity and risk of decline in glomerular filtration rate: Meta-analysis of individual participant data in a global consortium

Acute Increases in Serum Creatinine after Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes Mellitus: The ADVANCE Trial

Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults with Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial

China Kidney Disease Network (CK-NET) 2015 Annual Data Report

Blood pressure: at what level is treatment worthwhile? (vol 42, pg 127, 2019)

The George Institute for Global Health

The George Institute country sites:

Acknowledgement of Country